Cargando…

EZH2 Down-Regulation Exacerbates Lipid Accumulation and Inflammation in in Vitro and in Vivo NAFLD

Non-alcoholic fatty liver disease (NAFLD) is one of the most prevalent, chronic liver diseases, worldwide. It is a multifactorial disease caused by complex interactions between genetic, epigenetic and environmental factors. Recently, several microRNAs, some of which epigenetically regulated, have be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vella, Serena, Gnani, Daniela, Crudele, Annalisa, Ceccarelli, Sara, De Stefanis, Cristiano, Gaspari, Stefania, Nobili, Valerio, Locatelli, Franco, Marquez, Victor E, Rota, Rossella, Alisi, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Molecular Diversity Preservation International (MDPI) 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3876102/ https://www.ncbi.nlm.nih.gov/pubmed/24351808 http://dx.doi.org/10.3390/ijms141224154

Ejemplares similares

The Number of Liver Galectin-3 Positive Cells Is Dually Correlated with NAFLD Severity in Children
por: de Oliveira, Felipe Leite, et al.
Publicado: (2019)

Plasma Levels of Homocysteine and Cysteine Increased in Pediatric NAFLD and Strongly Correlated with Severity of Liver Damage
por: Pastore, Anna, et al.
Publicado: (2014)

Expression of insulin-like growth factor I and its receptor in the liver of children with biopsy-proven NAFLD
por: Alisi, Anna, et al.
Publicado: (2018)

Dual Role of MicroRNAs in NAFLD
por: Ceccarelli, Sara, et al.
Publicado: (2013)

Focal adhesion kinase depletion reduces human hepatocellular carcinoma growth by repressing enhancer of zeste homolog 2
por: Gnani, Daniela, et al.
Publicado: (2017)

LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease
por: Ceccarelli, Sara, et al.
Publicado: (2015)

Meta-Omic Platforms to Assist in the Understanding of NAFLD Gut Microbiota Alterations: Tools and Applications
por: Del Chierico, Federica, et al.
Publicado: (2014)

Combination Treatment with Hydroxytyrosol and Vitamin E Improves NAFLD-Related Fibrosis
por: Panera, Nadia, et al.
Publicado: (2022)

Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects
por: Romito, Ilaria, et al.
Publicado: (2021)

Correction to: Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects
por: Romito, Ilaria, et al.
Publicado: (2022)

Focal Adhesion Kinase: Insight into Molecular Roles and Functions in Hepatocellular Carcinoma
por: Panera, Nadia, et al.
Publicado: (2017)

Macrophage Activation in Pediatric Nonalcoholic Fatty Liver Disease (NAFLD) Correlates with Hepatic Progenitor Cell Response via Wnt3a Pathway
por: Carpino, Guido, et al.
Publicado: (2016)

The use of ultrasound in clinical setting for children affected by NAFLD: is it safe and accurate?
por: Nobili, Valerio, et al.
Publicado: (2011)

Emodin Prevents Intrahepatic Fat Accumulation, Inflammation and Redox Status Imbalance During Diet-Induced Hepatosteatosis in Rats
por: Alisi, Anna, et al.
Publicado: (2012)

The Role of Tissue Macrophage-Mediated Inflammation on NAFLD Pathogenesis and Its Clinical Implications
por: Alisi, Anna, et al.
Publicado: (2017)

The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver disease
por: Nobili, Valerio, et al.
Publicado: (2009)

Docosahexanoic Acid Plus Vitamin D Treatment Improves Features of NAFLD in Children with Serum Vitamin D Deficiency: Results from a Single Centre Trial
por: Della Corte, Claudia, et al.
Publicado: (2016)

Association between Serum Atypical Fibroblast Growth Factors 21 and 19 and Pediatric Nonalcoholic Fatty Liver Disease
por: Alisi, Anna, et al.
Publicado: (2013)

The exposure to uteroplacental insufficiency is associated with activation of unfolded protein response in postnatal life
por: Deodati, Annalisa, et al.
Publicado: (2018)

Enhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas: first implications
por: Ciarapica, Roberta, et al.
Publicado: (2011)

Causative role of gut microbiota in non-alcoholic fatty liver disease pathogenesis
por: Alisi, Anna, et al.
Publicado: (2012)

MicroRNA-101 is repressed by EZH2 and its restoration inhibits tumorigenic features in embryonal rhabdomyosarcoma
por: Vella, Serena, et al.
Publicado: (2015)

PNPLA3 rs738409 Polymorphism Predicts Development and Severity of Hepatic Steatosis but Not Metabolic Syndrome in Celiac Disease
por: Tortora, Raffaella, et al.
Publicado: (2018)

EZH2 as a Potential Target for NAFLD Therapy
por: Lim, Hyun Jung, et al.
Publicado: (2020)

Epidemiology and Natural History of NAFLD
por: Corte, Claudia Della, et al.
Publicado: (2015)

ADAR Enzyme and miRNA Story: A Nucleotide that Can Make the Difference
por: Tomaselli, Sara, et al.
Publicado: (2013)

Profiling of cell‐free DNA methylation and histone signatures in pediatric NAFLD: A pilot study
por: Buzova, Diana, et al.
Publicado: (2022)

Nutritional and lipidomics biomarkers of docosahexaenoic acid-based multivitamin therapy in pediatric NASH
por: Torquato, Pierangelo, et al.
Publicado: (2019)

Genetics, epigenetics and transgenerational transmission of obesity in children
por: Panera, Nadia, et al.
Publicado: (2022)

Pharmacological inhibition of EZH2 as a promising differentiation therapy in embryonal RMS
por: Ciarapica, Roberta, et al.
Publicado: (2014)

Indirect markers of fibrosis in chronic liver diseases: Is aspartate transaminase-to-platelet ratio (APRI) a useful test?
por: Corte, Claudia Della, et al.
Publicado: (2011)

Intrauterine Growth Retardation and Nonalcoholic Fatty Liver Disease in Children
por: Alisi, Anna, et al.
Publicado: (2011)

NAFLD exacerbates cholangitis and promotes cholangiocellular carcinoma in mice
por: Maeda, Shin, et al.
Publicado: (2021)

Non-high-density lipoprotein cholesterol (non-HDL-C) levels in children with nonalcoholic fatty liver disease (NAFLD)
por: Alkhouri, Naim, et al.
Publicado: (2014)

Cannabinoid Receptor Type 2 Functional Variant Influences Liver Damage in Children with Non-Alcoholic Fatty Liver Disease
por: Rossi, Francesca, et al.
Publicado: (2012)

Arterial Stiffness, Thickness and Association to Suitable Novel Markers of Risk at the Origin of Cardiovascular Disease in Obese Children
por: Manco, Melania, et al.
Publicado: (2017)

Commentary: The histone demethylase Phf2 acts as a molecular checkpoint to prevent NAFLD progression during obesity
por: Barbaro, Barbara, et al.
Publicado: (2018)

The Development of the Pediatric NAFLD Fibrosis Score (PNFS) to Predict the Presence of Advanced Fibrosis in Children with Nonalcoholic Fatty Liver Disease
por: Alkhouri, Naim, et al.
Publicado: (2014)

EZH2 Exacerbates Breast Cancer by Methylating and Activating STAT3 Directly
por: Zhao, Yi, et al.
Publicado: (2021)

Copper-catalyzed dicarbonyl stress in NAFLD mice: protective effects of Oleuropein treatment on liver damage
por: Santini, Silvano Junior, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_skpq6sg67lndm9cfkadbrb2u6t